Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

PET scans examine the tissues of the body at a cellular level. Because these tests can measure metabolic activity, such as oxygen use, blood flow and the rate at which specific areas of the body are ...

Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.

Medicare Part B covers outpatient PET scans when ordered by a doctor and considered medically necessary. PET scan costs can vary depending on whether you have the scan in a hospital as an inpatient, ...